Clotrimazole Vaginal Tablets/Cream Suppliers & Bulk Manufacturers

Available Forms: Vaginal Tablets/Cream

Available Strengths: 10 mg, 100 mg, 200 mg (vaginal tablets), 1% (cream)

Reference Brands: Mycelex(US); Fungusil(EU)

Category: Anti-fungal

Clotrimazole vaginal tablets and cream inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and damaging fungal cell membranes. They effectively treat vaginal candidiasis, offering benefits like targeted therapy, rapid symptom relief, broad antifungal activity, minimal systemic absorption, and high safety, making them a reliable choice for vaginal fungal infections. Clotrimazole Vaginal Tablets/Cream is available in Vaginal Tablets/Cream and strengths such as 10 mg, 100 mg, 200 mg (vaginal tablets), 1% (cream). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Clotrimazole Vaginal Tablets/Cream is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Clotrimazole Vaginal Tablets/Cream can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Clotrimazole vaginal tablets and creams are approved in the EU and US for treating vaginal candidiasis. In the EU, brands like Canesten are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA-approved clotrimazole vaginal products, including tablets and creams, are backed by comprehensive clinical data and pharmacovigilance requirements. Both regions require detailed dossiers for approval, ensuring product safety and efficacy. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market entry for clotrimazole vaginal formulations, helping you meet European and American standards for safe, effective antifungal therapy.